Back
Outlook Therapeutics Stock Predictions
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
5
OTLK
Outlook Therapeutics
Last Price:
1.54
Seasonality Move:
10.95%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MOREOutlook Therapeutics Stock Forecast
-
Is Outlook Therapeutics Stock Undervalued?
The current Outlook Therapeutics [OTLK] share price is $1.57. The Score for OTLK is 5, which is 90% below its historic median score of 50, and infers higher risk than normal. - OTLK is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Outlook Therapeutics Stock Go Up Next Year?
Data Unavailable
Outlook Therapeutics Stock Rating
Data Unavailable
Outlook Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
outlooktherapeutics.com
52-Week Data
52-Week High:
12.85
52-Week Low:
0.87
Prediction Charts
Market Cap:
37.14M
Price in USD:
1.57
Volume:
786.14K
Beta:
0.21
Technical Analysis
SMA50:
4.75
SMA100:
5.91
SMA200:
6.97
52-Wk Change:
-81.68%
Stock Predictions
-
Is Outlook Therapeutics stock public?
Yes, Outlook Therapeutics is a publicly traded company. -
What is the Outlook Therapeutics stock quote today?
The Outlook Therapeutics stock price is 1.57 USD today. -
How to buy Outlook Therapeutics stock online?
You can buy Outlook Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-21 | 5.22 | 5.13 | 5.29 | 5.06 |
| Nov-22 | 5.14 | 5.03 | 5.24 | 4.99 |
| Nov-25 | 5.09 | 4.93 | 5.18 | 4.92 |
| Nov-26 | 4.94 | 4.89 | 5.15 | 4.84 |
| Nov-27 | 0.98 | 1.70 | 2.21 | 0.87 |
| Nov-29 | 1.70 | 2.05 | 2.09 | 1.69 |
| Dec-2 | 2.07 | 2.03 | 2.42 | 1.98 |
| Dec-3 | 1.98 | 1.81 | 2.05 | 1.80 |
| Dec-4 | 1.85 | 1.66 | 1.85 | 1.59 |
| Dec-5 | 1.68 | 1.47 | 1.68 | 1.45 |
| Dec-6 | 1.56 | 1.52 | 1.58 | 1.47 |
| Dec-9 | 1.53 | 1.70 | 1.88 | 1.53 |
| Dec-10 | 1.74 | 1.61 | 1.85 | 1.60 |
| Dec-11 | 1.60 | 1.57 | 1.62 | 1.50 |
Outlook Therapeutics Earnings
Data Unavailable
Outlook Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.
* Outlook Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.